This guideline covers preventing type 2 diabetes in adult populations and communities who are at high risk. It aims to promote a healthy diet and physical activity at community and population level, and recommends how to tailor services for people in ethnic communities and other groups who are particularly at risk of type 2 diabetes.
For information on related topics see our cardiometabolic disease prevention and treatment summary page.
This guideline includes recommendations on:
- integrating national strategy on non-communicable diseases
- local joint strategic needs assessments and developing a local strategy
- interventions for communities at high risk of type 2 diabetes
- conveying messages to the local and whole population
- promoting a healthy diet: local and national action
- promoting physical activity: local and national action
- training those involved in promoting healthy lifestyles
Who is it for?
- Directors and commissioners
- GPs, practice nurses, dietitians and public health nutritionists and other health professionals
- Practitioners involved in physical activity interventions and community engagement
- Members of the public
Is this guideline up to date?
We checked this guideline in March 2018. We found no new evidence that affects the recommendations of this guideline.
Guideline development process
This guideline was previously called preventing type 2 diabetes: population and community-level interventions.
The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals and practitioners are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or the people using their service. It is not mandatory to apply the recommendations, and the guideline does not override the responsibility to make decisions appropriate to the circumstances of the individual, in consultation with them and their families and carers or guardian.
All problems (adverse events) related to a medicine or medical device used for treatment or in a procedure should be reported to the Medicines and Healthcare products Regulatory Agency using the Yellow Card Scheme.
Local commissioners and providers of healthcare have a responsibility to enable the guideline to be applied when individual professionals and people using services wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with complying with those duties.
Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible.